A cross-sectional nasopharyngeal carriage study to assess vaccine serotype coverage and antimicrobial susceptibility rates for S. pneumoniae in children aged 4–12 year
Latest Information Update: 12 Nov 2020
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal 10-valent vaccine conjugate; SIILPCV10
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 12 Nov 2020 New trial record
- 31 Oct 2020 Results published in the Vaccine